Stay updated on CABozantinib in NSCLC MET Clinical Trial
Sign up to get notified when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.

Latest updates to the CABozantinib in NSCLC MET Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' control was removed.SummaryDifference0.2%
- Check13 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check20 days agoChange DetectedThe web page has updated its facility names and locations, replacing previous terms with more specific identifiers, including the addition of 'cabozantinib' and a new version number.SummaryDifference3%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check49 days agoChange DetectedThe web page has been updated to a new version (v2.16.10), and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to CABozantinib in NSCLC MET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.